Necrotizing Enterocolitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
The small intestine proteome is changed in preterm pigs developing necrotizing enterocolitis in response to formula feeding.
|
18806098 |
2008 |
melanoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNAI3 expression correlates with tumor thickness in primary melanomas and thus, may be of prognostic value.
|
26753613 |
2016 |
melanoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Human SNAI3 mRNA was expressed in skin melanotic melanoma, lung epidermoid carcinoma, and germ cell tumor.
|
12579345 |
2003 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Taken together, our study reveals that miR-940 can suppress TGF-β-induced EMT and cell invasion by targeting Snail 3'-UTR mRNA in NSCLC.
|
31258781 |
2019 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, FOXD4 could directly bind the SNAI3 promoter during EMT in CRC and then facilitate CRC metastasis.
|
30252597 |
2018 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, FOXD4 could directly bind the SNAI3 promoter during EMT in CRC and then facilitate CRC metastasis.
|
30252597 |
2018 |
Amputated structure (morphologic abnormality)
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Both Snail1 and Snail3 have been shown to promote neuronal survival and astrocytic migration <i>via</i> anti-apoptotic and GTPases signaling following gecko tail amputation.
|
28484372 |
2017 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
SNAI3 expression correlates with tumor thickness in primary melanomas and thus, may be of prognostic value.
|
26753613 |
2016 |
Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SNAI2 mRNA was expressed in placenta, melanocyte, embryonic stem (ES) cells, leiomyosarcoma, neuroblastoma, and glioblastoma.SNAI3 mRNA was expressed in B cells.
|
16142376 |
2005 |
Adult Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SNAI2 mRNA was expressed in placenta, melanocyte, embryonic stem (ES) cells, leiomyosarcoma, neuroblastoma, and glioblastoma.SNAI3 mRNA was expressed in B cells.
|
16142376 |
2005 |
Childhood Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SNAI2 mRNA was expressed in placenta, melanocyte, embryonic stem (ES) cells, leiomyosarcoma, neuroblastoma, and glioblastoma.SNAI3 mRNA was expressed in B cells.
|
16142376 |
2005 |
Glioblastoma Multiforme
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
SNAI2 mRNA was expressed in placenta, melanocyte, embryonic stem (ES) cells, leiomyosarcoma, neuroblastoma, and glioblastoma.SNAI3 mRNA was expressed in B cells.
|
16142376 |
2005 |
Germ cell tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Human SNAI3 mRNA was expressed in skin melanotic melanoma, lung epidermoid carcinoma, and germ cell tumor.
|
12579345 |
2003 |
Childhood Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Human SNAI3 mRNA was expressed in skin melanotic melanoma, lung epidermoid carcinoma, and germ cell tumor.
|
12579345 |
2003 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Because SNAG zinc-finger proteins are transcriptional repressors implicated in carcinogenesis and embryogenesis, SNAI3 gene might be a potent target of pharmacogenomics in the field of oncology and regenerative medicine.
|
12579345 |
2003 |
Adult Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Human SNAI3 mRNA was expressed in skin melanotic melanoma, lung epidermoid carcinoma, and germ cell tumor.
|
12579345 |
2003 |